165 related articles for article (PubMed ID: 35402616)
41. Role of immunohistochemistry markers in neoplastic lung lesions.
Umakanthan S; Chalapathi Rao AV; Mohammed W
J Cancer Res Ther; 2021; 17(6):1382-1388. PubMed ID: 34916368
[TBL] [Abstract][Full Text] [Related]
42. Large cell neuroendocrine carcinoma of the lung: a histologic and immunohistochemical study of 22 cases.
Jiang SX; Kameya T; Shoji M; Dobashi Y; Shinada J; Yoshimura H
Am J Surg Pathol; 1998 May; 22(5):526-37. PubMed ID: 9591721
[TBL] [Abstract][Full Text] [Related]
43. Blood Chromogranin A Is Not Effective as a Biomarker for Diagnosis or Management of Bronchopulmonary Neuroendocrine Tumors/Neoplasms.
Matar S; Malczewska A; Oberg K; Bodei L; Aslanian H; Lewczuk-Myślicka A; Filosso PL; Suarez AL; Kolasińska-Ćwikła A; Roffinella M; Kos-Kudła B; Ćwikła JB; Drozdov IA; Kidd M; Modlin IM
Neuroendocrinology; 2020; 110(3-4):185-197. PubMed ID: 30995665
[TBL] [Abstract][Full Text] [Related]
44. Superficial primary small cell carcinoma of the esophagus: clinicopathological and immunohistochemical analysis of 15 cases.
Lu J; Xue LY; Lu N; Zou SM; Liu XY; Wen P
Dis Esophagus; 2010 Feb; 23(2):153-9. PubMed ID: 19515193
[TBL] [Abstract][Full Text] [Related]
45. Expression of TdT in Merkel cell carcinoma and small cell lung carcinoma.
Sidiropoulos M; Hanna W; Raphael SJ; Ghorab Z
Am J Clin Pathol; 2011 Jun; 135(6):831-8. PubMed ID: 21571955
[TBL] [Abstract][Full Text] [Related]
46. [Clinical and molecular pathological features of bronchopulmonary large cell neuroendocrine carcinoma].
Meng Y; Lian YB; Xu Y; Dong JQ; Song M
Zhonghua Yi Xue Za Zhi; 2022 Apr; 102(14):1020-1027. PubMed ID: 35399022
[No Abstract] [Full Text] [Related]
47. An Assessment of Circulating Chromogranin A as a Biomarker of Bronchopulmonary Neuroendocrine Neoplasia: A Systematic Review and Meta-Analysis.
Malczewska A; Kidd M; Matar S; Kos-Kudła B; Bodei L; Oberg K; Modlin IM
Neuroendocrinology; 2020; 110(3-4):198-216. PubMed ID: 31266019
[TBL] [Abstract][Full Text] [Related]
48. SCLC Subtypes Defined by ASCL1, NEUROD1, POU2F3, and YAP1: A Comprehensive Immunohistochemical and Histopathologic Characterization.
Baine MK; Hsieh MS; Lai WV; Egger JV; Jungbluth AA; Daneshbod Y; Beras A; Spencer R; Lopardo J; Bodd F; Montecalvo J; Sauter JL; Chang JC; Buonocore DJ; Travis WD; Sen T; Poirier JT; Rudin CM; Rekhtman N
J Thorac Oncol; 2020 Dec; 15(12):1823-1835. PubMed ID: 33011388
[TBL] [Abstract][Full Text] [Related]
49. The Use of Immunohistochemistry Improves the Diagnosis of Small Cell Lung Cancer and Its Differential Diagnosis. An International Reproducibility Study in a Demanding Set of Cases.
Thunnissen E; Borczuk AC; Flieder DB; Witte B; Beasley MB; Chung JH; Dacic S; Lantuejoul S; Russell PA; den Bakker M; Botling J; Brambilla E; de Cuba E; Geisinger KR; Hiroshima K; Marchevsky AM; Minami Y; Moreira A; Nicholson AG; Yoshida A; Tsao MS; Warth A; Duhig E; Chen G; Matsuno Y; Travis WD; Butnor K; Cooper W; Mino-Kenudson M; Motoi N; Poleri C; Pelosi G; Kerr K; Aisner SC; Ishikawa Y; Buettner RH; Keino N; Yatabe Y; Noguchi M
J Thorac Oncol; 2017 Feb; 12(2):334-346. PubMed ID: 27998793
[TBL] [Abstract][Full Text] [Related]
50. Neuroendocrine differentiation in non-small cell lung cancer and its relation to prognosis and therapy.
Howe MC; Chapman A; Kerr K; Dougal M; Anderson H; Hasleton PS
Histopathology; 2005 Feb; 46(2):195-201. PubMed ID: 15693892
[TBL] [Abstract][Full Text] [Related]
51. Prognostic implications of synaptophysin, CD56, thyroid transcription factor-1, and Ki-67 in pulmonary high-grade neuroendocrine carcinomas.
He Y; Zhao L; Tang X; Jiang Q; Zhao X; Cao Y
Ann Diagn Pathol; 2024 Feb; 68():152239. PubMed ID: 38006863
[TBL] [Abstract][Full Text] [Related]
52. Comparison of four DLL3 antibodies performance in high grade neuroendocrine lung tumor samples and cell cultures.
Brcic L; Kuchler C; Eidenhammer S; Pabst D; Quehenberger F; Gazdar AF; Popper H
Diagn Pathol; 2019 May; 14(1):47. PubMed ID: 31109352
[TBL] [Abstract][Full Text] [Related]
53. Comprehensive Characterization of the Genomic Landscape in Chinese Pulmonary Neuroendocrine Tumors Reveals Prognostic and Therapeutic Markers (CSWOG-1901).
Peng W; Cao L; Chen L; Lin G; Zhu B; Hu X; Lin Y; Zhang S; Jiang M; Wang J; Li J; Li C; Shao L; Du H; Hou T; Chen Z; Xiang J; Pu X; Li J; Xu F; Loong H; Wu L
Oncologist; 2022 Mar; 27(2):e116-e125. PubMed ID: 35641209
[TBL] [Abstract][Full Text] [Related]
54. Diagnostic value of four neuroendocrine markers in small cell neuroendocrine carcinomas of the cervix: a meta-analysis.
Huang R; Yu L; Zheng C; Liang Q; Suye S; Yang X; Yin H; Ren Z; Shi L; Zhang Z; Chen H; Fu C
Sci Rep; 2020 Sep; 10(1):14975. PubMed ID: 32917946
[TBL] [Abstract][Full Text] [Related]
55. ΔNp63 (p40) distribution inside lung cancer: a driver biomarker approach to tumor characterization.
Pelosi G; Rossi G; Cavazza A; Righi L; Maisonneuve P; Barbareschi M; Graziano P; Pastorino U; Garassino M; de Braud F; Papotti M
Int J Surg Pathol; 2013 Jun; 21(3):229-39. PubMed ID: 23486764
[TBL] [Abstract][Full Text] [Related]
56. Distinct Characteristics of Small Cell Lung Cancer Correlate With Central or Peripheral Origin: Subtyping Based on Location and Expression of Transcription Factor TTF-1.
Miyauchi E; Motoi N; Ono H; Ninomiya H; Ohyanagi F; Nishio M; Okumura S; Ichinose M; Ishikawa Y
Medicine (Baltimore); 2015 Dec; 94(51):e2324. PubMed ID: 26705222
[TBL] [Abstract][Full Text] [Related]
57. Insulinoma-associated Protein 1 Expression and Its Diagnostic Significance in Female Genital Tract Neuroendocrine Carcinomas.
Ting CH; Wang TY; Wu PS
Int J Gynecol Pathol; 2021 Sep; 40(5):452-459. PubMed ID: 33323849
[TBL] [Abstract][Full Text] [Related]
58. Neuroendocrine marker staining pattern categorization of small-sized pulmonary large cell neuroendocrine carcinoma.
Minami K; Tanaka Y; Ogawa H; Jimbo N; Nishio W; Yoshimura M; Itoh T; Maniwa Y
Thorac Cancer; 2019 Nov; 10(11):2152-2160. PubMed ID: 31583856
[TBL] [Abstract][Full Text] [Related]
59. The Value of Cytokeratin 5/6, p63 and Thyroid Transcription Factor-1 in Adenocarcinoma, Squamous Cell Carcinoma and Non-Small-Cell Lung Cancer of the Lung.
Argon A; Nart D; Veral A
Turk Patoloji Derg; 2015; 31(2):81-8. PubMed ID: 25944390
[TBL] [Abstract][Full Text] [Related]
60. hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors.
Jiang SX; Kameya T; Asamura H; Umezawa A; Sato Y; Shinada J; Kawakubo Y; Igarashi T; Nagai K; Okayasu I
Mod Pathol; 2004 Feb; 17(2):222-9. PubMed ID: 14657947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]